Introduction
Brucellae are facultative intracellular parasites that cause brucellosis in animals and man. Protective immunity has been most extensively studied in a mouse model in which protection was mediated by T lymphocytes'* and polyclonal antibodies of which the different specificities were not identified. 2-4 Opsonisation of Brucella organisms, either in vitro before injection' or in vivo during the post-challenge bacteraemic phase,2v6-10 confers on mice an immune protection that may represent a large part of the vaccinal immunity. 2* Whereas immune sera raised against the lipopolysaccharide extracted from smoothcell colonies (S-LPS) and against the outer-membrane protein (0MP)-linked peptidoglycan (PG) fractions were very efficient in protection,2 these sera contained too many antibody specificities to identify precisely the antigens involved (J. N. Limet, M. Plommet and G. Dubray, unpublished observations). For this reason, we used an indirect approach involving passive transfer of monoclonal antibodies (MAbs) to identify the antigens that elicit antibody-mediated protective immunity. In common with others, we demonstrated that MAbs directed against the polysaccharide 0-chain of S-LPS can confer protection on mice.** ' ' 9 Received 20 June 1990; accepted 22 Aug. 1990.
t Correspondence should be sent to Dr G. Dubray.
Brucella S-LPS bears major A and M specificities determined with monospecific sera and defining biovars of Brucella spp. ' MAbs of A or M specificity are able to protect mice passively in relation to the A or M S-LPS specificity of the challenge strain. l4 Other antigens may also be involved; in-vitro studies have indicated that at least two different types of antibody may help macrophages to ingest and digest Brucella organisms." In addition to S-LPS, major OMPs of the PG fraction may be putative candidates for humoral protective antigens because highly protective polyclonal anti-PG immune sera contain antibodies against these proteins.
We have now examined 26 MAbs directed against seven protein components of the outer membrane for protective ability in the mouse model.
Materials and methods

Bacterial strains
Challenge strains. B. abortus strain 544 ( S ) and (R) variants were obtained from the Station de Pathologie de la Reproduction (Nouzilly, Tours). Purity and phase were checked by standard procedure^.'^ Whole bacterial S and R cells for binding studies. Cell cultures were grown at 37°C for 48 h on slopes of Trypticase Soy Agar (TSA) ; BioMCrieux, Marcy-l'Etoile, France) supplemented with yeast extract (Difco) 0.1% w/v. The bacteria were killed by addition of 20 pl of peracetic acid (Aldrich-Chimie, Strasbourg, France) 5% v/v to each 1-ml volume of 10" cells/ml, followed by incubation overnight at room temperature. Before use, killing efficiency was checked by spreading 0.2-ml samples of each cell suspension, after three washes in sterile distilled water, on TSA.
Bacterial fractions. Cell walls, and insoluble cell-wall fraction (PG fraction) obtained after boiling cell walls in sodium dodecyl sulphate (SDS) 4% solution, were extracted as described previously. ' Briefly, cells were inactivated by heating at 65°C for 1 h and broken with glass beads in a Braun MSK Homogenizer or a DynoMill apparatus (W. A. Bachofen, Basel, Switzerland). Crude cell walls were recovered by centrifugation (53 OOOg, 4"C, 1.5 h). Cell walls from B. melitensis strain B115 (R) were obtained by treating crude cell walls with Triton X-100 1% in 0.2 M NaC1, 0.01 M MgC12 for 30min at 20"C, then washing them six times in distilled water before lyophilisation. PG fraction from B. melitensis strain H38 (R) was obtained by treating crude cell walls with SDS 4% in the Laemmli sample buffer for electrophoresis. Insoluble fractions were recovered by centrifugation, washed six times in distilled water and then lyophilised.
Cell extracts of B. abortus strain B115 (R) were obtained by ultrasonication. Cells were inactivated by heating at 65°C for 1 h, washed three times in NaCl 0.9% and exposed to ultrasonication for 15 min in 1 mM EDTA, 30 mM Tris, pH 8. The ultrasonicated cells were then centrifuged for 10 min at 4000 g and the supernate was recovered.
LPS fractions. S-LPS fraction of B. abortus strain B3 (S-LPS of A > M specificity) was prepared by the phenol-water method. l7 were immobilised on microtitration plates (Greiner labortechnic-Stuttgart) by capture with rabbit antibrucella immunoglobulins at a coating concentration of 10 pg/ml. Hybridoma supernates were serially diluted (from 1 in 10 to 1 in 590490) in glycine buffer saline-EDTA-Tween (0.17 M NaCl, 0.1 M glycine, 6 mM NaN3, 50 mM EDTA, Tween 80 0.1%, pH 9-2). Binding to whole bacterial cells was detected with peroxidase-conjugated goat anti-mouse immunoglobulins (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) diluted in PBS-T. Excess of reagents between the different incubations was removed by five washings with saline containing Tween 20 0.05%. For substrate solution, 52 mM ABTS (2,2-azino-di- [ 3- ethyl-benzthiazoline sulp honate] ; Boe hr inger , Mannheim, Germany) was dissolved in water and autoclaved at 121°C for 15 min. The working substrate solution was made by adding 1 ml of ABTS stock solution to 50ml of 0.1 M sodium citrate buffer, pH 4.2, and 1 ml of H 2 0 2 (125 pl of H202 30% in 10 ml of distilled water).
Production of monoclonal antibodies (MAbs)
The ELISA titres were estimated as the highest dilutions that gave an increase in light absorbance at 414nm (A414) more than twice the mean of the corresponding blank values (without MAb but with conjugate and substrate).
Protection of mice
MAbs were screened for protection of mice as described previously,' ', l 4 except that two groups of four mice were used for each MAb, at ascitic fluid dilutions of 1 in 5 and 1 in 50. MAbs were injected subcutaneously (0.1 ml) 1 day before the standard intravenous challenge with B. abortus strain 544 (2 x lo5 cfu). The mice were killed 7 days after challenge; individual spleen counts were made and were expressed as mean log,, and SD cfu per group. Two successive experiments were performed, with 12 and 16 MAbs respectively. Each experiment included two control groups, one of which received saline (negative control), the other anti-S-LPS MAb of A specificity (B66/04F09, IgG2a) as positive control. The statistical significance was determined after variance analysis by one-side comparison of means with the negative control mean according to Dunnett's procedure. l9 electrophoresis unit (LKB-Produkter AB, Bromma, Sweden). After electrophoresis, the proteins were transferred to nitrocellulose with a Transblot apparatus (Biolyon, Dardilly, France) operated at 12 V for 2 h. Unoccupied sites on the nitrocellulose membranes were blocked by incubation for 30 min in Tris-buffered saline (TBS) with bovine serum albumin (BSA) 3% at room temperature with agitation.
The membranes were then incubated successively at room temperature overnight with hybridoma supernates diluted 1 in 2 in Tween (Tw) TBS BSA 1%, for 1 h with RAM and finally for a further hour with peroxidase-conjugated protein A, each diluted 1 in 250 and 1 in 1000, respectively, in the same buffer. Protein A (Sigma) was conjugated with horseradish peroxidase (Sigma) by a modification of the method of Nakane and KawaoY2* as described previously. 21 The protein : enzyme ratio was 1 : 2. Washings between incubation periods were with Tw-TBS. After two final washings with Tw-TBS and two washings with TBS, the blots were developed by incubation at room temperature in a solution of 4-chloro-1 -naphthol
Immunoblot examination of MAbs
Protein antigens in sonicated cell extracts of B. melitensis strain B115 (R) were separated by SDSpolyacrylamide gel electrophoresis (SDS-PAGE), as originally described by Laemmli,22 in a 2001 vertical 
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* MAbs were injected subcutaneously 1 day before challenge with 200 000 cfu of strain 544(S); mice were killed after 7 days and Brucellae from spleen were counted.
7
Higher dilution that gave an A414 value greater than twice the blank value.
$Maximal A414 value after subtraction of blank value.
6 p < 0.01 in comparison with untreated control groups (one-sided Dunnett's test).
(BioRad, Richmond, USA) 0.06% w/v and 5 mM H 2 0 2 in TBS. The reaction was stopped by washing with distilled water.
Results
Protection conferred on mice
In experiment 1 (table I) ... anti-25-27 Kda protective MAb but were not able to protect mice from infection.
Discussion
Polyclonal immune sera raised against the PG fraction that reacted strongly with OMPs and S-LPS in immunoblots were highly protective in the mouse m 0 d e 1 .~~~ Having shown that MAbs directed against the LPS A or M dominant antigen conferred good protection, ' we produced 26 MAbs against OMPs16 which were screened in our mouse model for protection. Three were able to induce a significant reduction of spleen counts at day 7 after challenge. Using a similar approach, Montaraz et a1.8 obtained protection with 0-polysaccharide (LPS)-specific MAbs but no protection with two anti-porin (37-38 Kda) IgM MAbs. The protection conferred by our three anti-OMP MAbs even if highly significant, was quite low compared with that conferred by the S-LPS positive control MAb (B66/04F09). The low protective effect induced by anti-OMP MAbs may be related to weaker opsonisation resulting from poor fixation at the cell surface, possibly because of low accessibility and avidity. One MAb showed a protective activity only at a dilution of 1 in 50; a detrimental effect following high-dose antibody administration in animals challenged with Staphylococcus aureus has been shown23 which may be due to blockade of the immune system. There was no clear correlation between binding of anti-OMPs MAbs to the challenge S strain and its R mutant and protection. This probably means that the binding of MAbs to cells in vitro is only a part of the protective action of MAbs in uivo. A complex mechanism of action of antibodies may operate during ingestion and killing of Brucella organisms by macro phage^'^ and anti body-dependent cell-mediated cytotoxicity may also be involved. 24 MAbs protective against other gram-negative bacteria have been described. 25-28 However, most mouse models of protection are based on lethality and comparisons are difficult. Nevertheless, Sawada et al.
showed that MAbs to OMPs were much less protective than MAbs to S-LPS against infection of mice with Pseudomonas aeruginosa. 27 The role of anti-OMP antibodies in immunity to brucellosis remains uncertain. Using the MAbs we have developed, it should be possible to investigate the effects of these MAbs in vivo on the first phase of the infection, the possible synergy of two or more MAbs, and the mechanisms at the cellular level of digestion and killing of intracellular Brucella organisms. 
